RxDoctor Payments Data

Dan Yamini

Plastic and Reconstructive Surgery · Los Angeles, CANPI 1962625111

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 79.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $3,499 and has fallen 95.8% since, to $146 in 2025.

$10,554in general payments, 2019–2025

Across 163 payments — averaging $64.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$8K
  • KCI USA, Inc.$800
  • Tepha Inc$442
  • Merz North America, Inc.$367
  • Bard Peripheral Vascular, Inc.$172
  • Apyx Medical Corporation$137
  • plus $299 from 6 others

What the payments were for

  • Consulting fees$8008%
  • Speaking & faculty fees$5,63053%
  • Food & beverage$4,06539%
  • Education$591%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,554 in reported general payments places this provider in the 80th percentile of 349 plastic and reconstructive surgery providers in California.

See all plastic and reconstructive surgery providers in California

Other plastic and reconstructive surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →